DM Flashcards
ADPIE DM
Assessment
Health History
( OLD CARTS, Patients medical history, Family history, Lifestyle)
Symptom Assessment
(Polyuria, polydipsia, polyphagia, fatigue, weight loss)
Physical examination:
(Vital signs, BMI, focused Assessment “Cardiovascular, neurological, integumentry”)
Common Symptoms of DM
Polyuria, polydipsia, polyphagia, fatigue, weight loss
ADPIE DM
Diagnosis
Imbalanced nutrition: More than Body requirements
Risk for Unstable Blood Glucose Level
Deficient knowledge related to diabetes self-management
ADPIE
Planning
SMART
Have 110 blood glucose for 1 month during every reading
Weight 220 lbs by the 1st of July
Incorporate 2 standard servings of vegetables in every dinner.
(Develop CARE PLAN to meet: nutrition, medication management, exercise, and education)
ADPIE DM
Implementation
Patient education: insulin administration, oral meds, diet, exercise, monitoring of blood glucose
Medication Administration: proper Route, Dosage, Time
Dietary Management
Promote Physical Activity
ADPIE
Evaluation
Monitoring changes in blood glucose
Weight Management
Revising Care Plan
Continued Education
5 rights of medication
Patient
Medication
Dose
Route
Time
SBAR
Situation
Include which information
Nurses Name
Patients Name (Age)/ Room Number
Reason for admission (brief, e.g. uncontrolled glucose levels)
SBAR
Background
Patients Name
Medication (Name, Dose, Amount, Route)
Glucose Monitoring (Frequency)
Value of last Glucose Reading
(Recent changes or interventions “Adjustments in Insulin Dosage/ Dietary Modifications)
SBAR DM
Assessment
Patients Name
Stable / Unstable
Vital signs, mental status, Symptoms of DM (Polyuria / Polydipsia)
Patients Complaints (Symptoms)
Plan of care ( medications, restrictions diet, monitoring)
SBAR
Recommendation
Specific
Continue with current insulin regimen and monitor glucose
Notify provider if significant change occurs
Patient recieves education on DM adheres to prescribed diet
Glucose can only enter cells that contain
Beta cells and insulin
(Lock & Key)
Glucose is converted into ATP by cellular respiration in a process called
Glycolysis
Glycogenesis is…
Glucose converted to glycogen
Glycogen is….
the stored form of glucose that’s made up of many connected glucose molecules.
_______ role in the body is toprevent blood glucose levels dropping too low. To do this, it acts on the liver in several ways: It stimulates the conversion of stored glycogen (stored in the liver) to glucose, which can be released into the bloodstream. This process is called glycogenolysis.
Glucagon’s
Glucagon’s role in the body is to ___________To do this, it acts on the liver in several ways: It stimulates the conversion of stored glycogen (stored in the liver) to glucose, which can be released into the bloodstream. This process is called glycogenolysis.
prevent blood glucose levels dropping too low.
Glucagon’s role in the body is to prevent blood glucose levels dropping too low. To do this, it acts on the liver in several ways: It stimulates the conversion of stored _______ (stored in the liver) to glucose, which can be released into the bloodstream. This process is called glycogenolysis.
glycogen
Glucagon’s role in the body is to prevent blood glucose levels dropping too low. To do this, it acts on the liver in several ways: It stimulates the conversion of stored glycogen (stored in the liver) to glucose, which can be released into the bloodstream. This process is called _______.
glycogenolysis
What does Glucagon do to blood sugar levels
Raises them
Conversion of Glycogen to Glucose
When Glucose levels rise give Insulin to reduce blood sugar
True or False
True
Insulin decides what (glycogen / glucose) sugar is used for energy and which to store (glycogen/ glucose)
Glucose/ glycogen
Biphasic pattern
(Name)
low - level
Around the clock
(Name)
Bursting, rising-release
Meals
Basal
(Low - level )
Around the clock
Postprandial
(Bursting, rising-releas)
Meals
Types of diabetes
Insulin resistance and impaired insulin secretion
Destruction of pancreatic beta cells
TPYE II
Insulin resistance and impaired insulin secretion
TYPE I
Destruction of pancreatic beta cells